Galafold Cap.

Ingredient

Migalastat Hydrochloride

Content

150mg (123mg as Migalastat)

Indication

Long-term treatment of patients aged 12 years and older with a confirmed diagnosis of Fabry disease (α-galactosidase A deficiency) and who have an amenable mutation